SC
ACAD icon

Samlyn Capital’s Acadia Pharmaceuticals ACAD Stock Holding History

Samlyn Capital’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-789,061
Closed -$20.4M – 164
2021
Q1 		$20.4M Buy
789,061
+195,896
+33% +$8.62M 0.3% 73
2020
Q4 		$31.7M Sell
593,165
-87,029
-13% -$4.32M 0.49% 68
2020
Q3 		$28.1M Buy
+680,194
New +$29.4M 0.52% 62
2017
Q2 		– Sell
-125,800
Closed -$4.33M – 111
2017
Q1 		$4.33M Buy
+125,800
New +$4.44M 0.11% 122

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $950M AUM 57.92% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return